Antibody-induced erythrophagocyte reprogramming of Kupffer cells prevents anti-CD40 cancer immunotherapy-associated liver toxicity by Florence Vallelian, Marc Pfefferlé, Irina L Dubach, Raphael M Buzzi, Elena Dürst, Nadja Schulthess-Lutz, Livio Baselgia, Kerstin Hansen, Larissa Imhof, Sandra Koernig, Didier Le Roy, Thierry Roger, Rok Humar, Dominik J Schaer

“…This unique mode of action prevented necroinflammatory liver disease following high-dose administration of anti-CD40 mAbs. …”
Get full text

The changing demographics and severity in hospitalized patients across COVID-19 variants: A national cohort study by Priyanka Parajuli, Lara A.C. Phipps, Roy Sabo, Rasha Alsaadawi, Amanda Robinson, Evan French, Richard K. Sterling, N3C. consortium

“…Results: The severity of SARS-CoV-2 decreased in the omicron-subsequent wave with decreased utilization of mechanical ventilation and decreased 30-day mortality among patients with comorbidities like diabetes mellitus, obesity, and liver disease. Although with each subsequent wave, the sex distribution remained equal and constant, there was an increase in rates of diabetes, liver disease, and respiratory disease amongst patients hospitalized with COVID-19 over the COVID waves despite the decreasing 30-day mortality and mechanical ventilation. …”
Get full text

Reporting a Case of Solid Pseudopapillary Neoplasm of the Pancreas in a 44-Year-Old Woman with Parallel Analysis of Literature by Sargun Singh, Qing Zhao, Teviah E. Sachs, Kevan Hartshorn

Get full text

Cytomorphological Changes in the Hepate of the White Sea Coastal Cod (Gadus morhua maris-albi Derjugin, 1920) during Parasitic Invasions by Shakurova N.V., Kudryavtseva E.V.

“…The signs of fatty liver disease in specimens with the high degree of infestation were revealed. …”
Get full text

Exocrine pancreatic insufficiency and causes of abdominal symptoms in diabetes patients by Roland Kadaj-Lipka, Grażyna Rydzewska

“…Gastrointestinal side effects include pancreatopathy, small intestinal bacterial overgrowth, oesophageal dysmotility, gastroesophageal reflux disease, gastroparesis, neuropathy, and nonalcoholic fatty liver disease.…”
Get full text

Challenges faced during antitubercular therapy by B. K. Likhitha, Shreeshail Anjutagi, Keertivardhan D. Kulkarni, Madhav Mahawar

“…This case report discusses regarding a 48-year-old male with drug-sensitive tuberculosis (TB) and alcoholic liver disease, who experienced significant side effects during antitubercular therapy. …”
Get full text

Panhypopituitarism due to Absence of the Pituitary Stalk: A Rare Aetiology of Liver Cirrhosis by Marta Gonzalez Rozas, Lidia Hernanz Roman, Diego Gonzalez Gonzalez, José Luis Pérez-Castrillón

“…Insulin resistance is the main pathophysiological axis of metabolic syndrome and is the causal factor in the development of nonalcoholic fatty liver disease (NAFLD). We present the case of a young patient with liver cirrhosis of unknown aetiology that was finally attributed to panhypopituitarism.…”
Get full text

MORIX: Machine learning-aided framework for lethality detection and MORtality inference with eXplainable artificial intelligence in MAFLD subjects by Domenico Lofù, Paolo Sorino, Tommaso Colafiglio, Caterina Bonfiglio, Rossella Donghia, Gianluigi Giannelli, Angela Lombardi, Tommaso Di Noia, Eugenio Di Sciascio, Fedelucio Narducci

“…Metabolic dysfunction-associated fatty liver disease (MAFLD) introduces new diagnostic criteria for fatty liver disease that are independent of alcohol consumption and viral hepatitis infection. …”
Get full text

Short-term Outcomes of Pancreatoduodenectomy in Patients with Liver Cirrhosis: A Systematic Review and Meta-analysis by Shahab Hajibandeh, MRCS, Shahin Hajibandeh, FRCS, Alwin Puthiyakunnel Saji, Ayman Ashabi, MRCS, Christopher Brown, FRCS, Nicholas G Mowbray, FRCS, Matthew Mortimer, FRCS, Guy Shingler, FRCS, Amir Kambal, FRCS, Bilal Al-Sarireh, FRCS, PhD

“…Whether such risks increase with the severity of the liver disease or decrease with optimization of underlying liver disease should be the focus of future research.…”
Get full text

Knowledge, attitudes and practices to hepatitis B among South African primary healthcare staff by Atlegang Mashilo, Itumeleng Mompati, Refilwe Ramakatane, Didintle Sebitloane, Naledi Sibi, Philippa C. Matthews, Cornel Van Rooyen, Dominique Goedhals, Sabeehah Vawda

“…Background: Hepatitis B virus (HBV), a significant cause of liver disease globally, is recognised as a 2030 elimination target by the World Health Organization (WHO). …”
Get full text

Complementary and Alternative Medicine Use by Patients Chronically Infected with Hepatitis C Virus by Colin P White, Gerilynn Hirsch, Sunil Patel, Fatin Adams, Kevork M Peltekian

“…The use of CAM is also popular in patients with chronic liver disease but is not well documented. The extent of use of CAM in chronic hepatitis C virus (HCV) infected patients was determined, and the demographic and clinical data between users and nonusers of CAM was compared.…”
Get full text

Clinical Resolution of Osmotic Demyelination Syndrome following Overcorrection of Severe Hyponatremia by Ruhin Yuridullah, Vinod Kumar, Sushant Nanavati, Monisha Singhal, Chandra Chandran

“…Osmotic Demyelination Syndrome (ODS) occurs after rapid overcorrection of severe chronic hyponatremia usually in those with a predisposition such as chronic alcoholism, malnutrition, or liver disease. Rarely, do patients make a full recovery. …”
Get full text

CIHR Canadian HIV Trials Network Co-Infection and Concurrent Diseases Core: Updated Canadian Guidelines for the Treatment of Hepatitis C Infection in HIV-hepatitis C Coinfected Adu... by Mark Hull, Stephen Shafran, Alice Tseng, Pierre Giguère, Marina B Klein, Curtis Cooper

“…Management of HIV-HCV coinfection is more complex due to the accelerated progression of liver disease, the timing and nature of antiretroviral and HCV therapy, mental health and addictions management, socioeconomic obstacles and drug-drug interactions between new HCV direct-acting antiviral therapies and antiretroviral regimens.…”
Get full text

Early Changes in Hepatitis C Virus (HCV) RNA Levels Predict Response to Interferon Treatment in Non-Cirrhotic HCV Patients by Glen Fallows, Kelly Kaita, Gerald Minuk, Faye Penner, Gerry Smart, Magdy Dawood, Barry Rosser

“…The role of hepatitis C virus (HCV) RNA quantification in determining ideal interferon (IFN) treatment of noncirrhotic HCV liver disease is uncertain. The specific aim of this study was to determine whether measurement of baseline HCV RNA or changes in HCV RNA levels ( HCV RNA) early during therapy predict response to IFN in noncirrhotic HCV patients.…”
Get full text

Pregnancy Following Liver Transplantation: Review of Outcomes and Recommendations for Management by Kuljit S Parhar, Paul S Gibson, Carla S Coffin

“…Liver transplantation is considered to be the treatment of choice for end-stage liver disease and its success has led to an increase in the number of female liver transplant recipients who are of childbearing age. …”
Get full text

Characteristics of Hepatitis C Virus Infection in HIV-Infected People by Curtis L Cooper, Andrew D Badley, Jonathan B Angel

“…Co-infected individuals develop histological and clinical features of HCV liver disease more rapidly than HIV-seronegative patients. …”
Get full text

Laparoscopic Sleeve Gastrectomy in a Morbidly Obese Patient with Myasthenia Gravis: A Review of the Management by Megana Ballal, Tracey Straker

“…This report describes the case of a 27-year-old morbidly obese woman with a past medical history significant for myasthenia gravis and fatty liver disease undergoing bariatric surgery. Anesthesia was induced with intravenous agents and maintained with an inhalational and balanced intravenous technique. …”
Get full text

Vibrio vulnificus specie isolation in series blood culture. A case report. by Elio Jesús Núñez Tamayo, Susana Chamero Melgarejo, Julián Viera Yanez, Belkys Rodríguez Llerena, Nancy Ramírez Martínez, Dania Peñaranda Pordomingo, Annia Alvarado Borges

“…This papers contains a report of a case with Vibrio vulnificuls, gram negative micro organism that ferments carbohydrates and that is positive to the oxidase test and halophile in a patient with history of heart and liver disease who was assisted at the Intensive Care Emergency Unit ( ICU )of the ¨Dr. …”
Get full text

Organizing Pneumonia Associated with Pegylated Interferon α and Ribavirin Therapy by Amit Chopra, Creticus Marak, Narendrakumar Alappan, Chang Shim

“…Hepatitis C virus infection is the leading cause of chronic liver disease in the United States of America. Pegylated interferon α and ribavirin combination is the mainstay of treatment. …”
Get full text

Liver metastases in gastroenteropancreatic neuroendocrine tumours – treatment methods by Paweł Gut

“…Surgical approaches that allow the safe treatment of multiple, bilateral, large tumours, and that combine extirpative, ablative and interventional therapies, have expanded the population of patients with neuroendocrine tumors (NET) liver metastases (LMs) who can benefit from aggressive treatment of their liver disease. Pre-treatment staging often includes the biochemical assessment of serologic markers such as serotonin, insulin, vasoactive intestinal peptide, and chromogranin, even in patients without clinically apparent hormonal excess. …”
Get full text